Fidelity SPDR Advertisement
Home > Boards > US OTC > Miscellaneous >

BioNeutral Group, Inc. (BONU)

Add BONU Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator stock_MD, VortMax
Search This Board:
Last Post: 9/20/2014 11:14:00 PM - Followers: 198 - Board type: Free - Posts Today: 0

Executive Interview: BioNeutral Group CEO Mark Lowenthal
Mar 5, 2014 8:57 AM | about stocks: BONU

My executive Q & A series has been going very well. I've interviewed some great CEO's in the Small and microcap arenas. Earlier this week I was fortunate enough to have a chance to site down with Mark Lowenthal, CEO of Bioneutral Group Inc. This company was one that I had reported on a few months ago and have been following since mid November of 2013. It seems like the company has just started to build in the 2014 year and after having had the chance to discuss BONU with the company's CEO, I feel that this will be something that I'll continue to follow throughout the year:

Executive Interview with BioNeutral Group CEO Mark Lowenthal

1. In a few words, can you explain what the company does or is planning to do?

Over the last seven years our Company has developed, tested and is now in the process of commercially introducing a series of state of the art and highly competitive sterilization and bioneutralizer products (products that kill micro-organisms on surfaces and eliminate odors in the air at the cellular level). The products have wide applications in various health and life science segments (acute and long-term care, veterinary care, first response, laboratory research, pharma manufacturing), and in industrial segments (janitorial, sanitation, mold remediation, hospitality), both here at home and abroad. They also have substantial applications across various government and consumer markets as well.

With our testing substantially performed as of late 2012, we began 2013 by first accessing the various marketplaces, then developed a focused sales plan, and finally in the later part of the year began to engage independent sales agents, i.e. independent sales groups and distributors.

Overall we've found the markets extremely receptive, and beginning in 2014 we now believe we are finally beginning to be in a position to leverage our technology. To date we have been severely hampered by being undercapitalized and lacking the resources with which to do this.

2. What Direction do you see your industry headed toward?

There is a continually growing movement on a worldwide basis towards higher standards of sterility and high-level disinfection across a wide variety of market segments which we plan to engage in. In this respect, as a high quality and highly efficacious supplier we have high expectations.

3. What are the key risks the company faces right now?

We feel our chief constraint is our access is to capital. Like most small companies, locating cost effective sources of capital can be (and in the past has proven to be) somewhat tricky. However I will say we are making progress in that area and as things stand currently, I feel our prospects have improved.

4. What projects are you currently looking to begin and/or complete?

We are currently in the process of negotiating a supply agreement and a private label transaction with two major market distributors for coverage both here at home and abroad. In addition, we are also in discussions with a major distributor for a key market segment, and we are close to an agreement to begin consumer testing our Ogiene products overseas.

5. What are the current challenges you're facing that could prevent or slow progress from this/these project(s)?

As mentioned above, access to capital.

6. If all goes as planned, how much revenue does the company anticipate generating from this/these project(s)?

We are in the early stages of commercialization and in the process of collecting new market data all the time, and that being said, over the next five years or so my goal is to have the Company generate sales in the $150,000,000 range.

7. How are you currently marketing your product/brand?

By engaging with firms for supply agreements, distribution agreements, private label transactions and independent sales groups.

8. Where do you think the most significant growth will occur for the company over the next 3-6months?

Four key market segments, laboratory research, pharmaceutical and compound manufacturing, janitorial/sanitation and mold remediation

9. You're the CEO of a small cap company. What is the major discerning factor that sets the company apart from the rest and gives you a competitive advantage?

Our proprietary combinational chemistry that makes up our technology; which is highly effective, highly competitive and cost effective.

10. What are you doing to capitalize on the company's strengths and minimize the company's weakness?

We are actively engaged in micro financial markets and are accessing capital there to finance much of our operations and plan to continue to do so.

11. Are you self-funding your projects or do you work with funding sources as a means for operational cash flow?

Our goal is to become financially self-sufficient through our operations as soon as possible. At the current time we are working with a few lending sources.

12. Is there anything that shareholders should know about you personally?

I am a highly trained and fairly successful professional manager. Shareholders can find my bio on line. I am heavily invested in the company, and as such am committed to its success.

It was a pleasure speaking with Mr. Lowenthal and I would like to thank him for his time. Having had the opportunity to discuss several specific topics sheds more light on the company's direction for the new year and even beyond. Until next time,

The Importance about Spectrasan:

Ygiene and Ogiene from BONU is listed as the top products on the Spectrasan website:

Ygiene and Ogiene from BONU is listed as the top products on the Spectrasan website:
Read below from some older news to possibly link an affiliation:

BioTech Medical, LLC, a privately held company announced Monday that it is prepared with its new product SpectraSan 24, a new advanced surface disinfectant to immediately respond to the current Influenza A (H1N1) epidemic. BioTech Medical, LLC is a distributor for PURE Bioscience (Nasdaq: PURE), creators of the patented silver dihydrogen citrate (SDC) antimicrobial. …

PURE trades on the NASDAQ at $1.10+ per share:
These relationships are definitely something that we should keep our eye on for sure. 

Dr. Andy Kielbania, was with was Rohm and Haas which was a very huge multi-billion dollar company.  In my opinion, him being here with BONU is a huge hint that he is not here because of something that could be considered small change.  See below: 


Rohm and Haas | Company Information from ICIS

In April 2009, Dow Chemical completed its $78/share takeover of Rohm and Haas. Dow Chemical will integrate its acquired Rohm and Haas business into the newly formed ‘Advanced Materials Division’ and will be headed by Pierre Brondeau.
Dow Chemical bought out Rohm and Haas for $78.00 per share.  When you click on the old Rohm and Haas website, it takes you to Dow Chemicals website:

For inquiring minds, Dow Chemicals trade on the NYSE at $40.00+ per shareunder the ticker pf DOW:

More proof that Dr. Andy Kielbania, PhD, CEO, Chief Scientific Officer and Director for BONU was an instrumental part of Rohm and Haas which was bought out by Dow Chemical:
At Rohm and Haas we thank Dr. Edward Firouztale, Dr. Peter Cartier, and Dr. Andy Kielbania for scholarly discussions and assistance with the research.

Dr. Andy Kielbania, PhD 
The Chief Scientist with over 35 years experience in the specialty chemical field, including coatings, adhesives, personal care, biotechnology and pharmaceuticals. He has previously held positions at Rohm and Haas (do people realize how big these Companies are?) where he assumed senior level positions in research and development. In 1993, Dr. Kielbania joined National Starch and Chemical Company (part of ICI) as research and development Director. Dr. Kielbania is the inventor on 21 patents and has published many technical articles. He is the winner of awards in new technology development to improve new business opportunities and also research and development improvements. He received his PhD in organic chemistry from the University of California at Berkeley (good grief it does not get any better than that other than Harvard and MIT!) and has post doctoral experience at Stanford University



Disinfectant that quickly wipes out swine flu, anthrax spores, is being tested at NJIT


Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature.
            Hospital induced Staph Infection & H1N1 Flu Virus

The required EPA testing procedures occurred at ATS Labs.^BONU


BioNeutral’s Ygiene™ Kills Dangerous MRSA in Seconds. Hospital Acquired Infections (HAI’s), The big one ( staph Infection)

BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based life science company, reports that its Ygiene™ Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature. The required EPA testing procedures occurred at ATS Labs.

MRSA, or Methicillin-resistant Staphylococcus aureus, is a very serious health threatening microorganisms present in many health care facilities and community environments. MRSA is one of the more serious antibiotic resistant heath threatening microorganisms that contributes to Hospital Acquired Infections (HAI’s). In the U.S. alone, over two million people annually are afflicted with Hospital Acquired Infections with approximately one hundred thousand people dying. Worldwide Hospital Acquired Infections are on the rise and will lead to hundreds of thousands needless deaths annually. MRSA is also becoming a serious issue associated with Community Acquired Infections such as school and campus settings. With its power to rapidly and totally eliminate MRSA in less than one minute, BioNeutral’s Ygiene™ Hospital Grade Antimicrobial will be a significant part of the future solution for controlling Hospital Acquired Infections and Community Acquired Infections.


BioNeutral’s Consumer Grade Ygiene™ Delivers a 100% Total Kill on Contact of Swine Flu (H1N1) Virus – For the Home^BONU

BioNeutral Announces 100% Total Kill of Swine Flu (H1N1) on Virtual Contact of This Pandemic Causing Virus in an Independent ...^BONU

Swine Flu Campaign Waits on Vaccine
Only Third of Supply Is Expected for First Round of Vast Effort

By Rob Stein
Washington Post Staff Writer
Sunday, August 23, 2009


Sort by: 


New York Times

Monday, August 24, 2009

BioNeutral Group ($BONU) - June 2011  PowerPoint


BioNeutral Group Hosts Discussions with Four of the World’s Largest Health Care Companies

All Interested in Ygiene™ Sporicidal Antimicrobial Performance on Skin and Surfaces

Business Wire

Monday, August 24, 2009

211 Warren Street
Newark, NJ 07103
Phone: 973.577.8003
Fax: 973.577.8004


Daily View

Monthly View

3 Month Daily View


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BONU News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 09/11/2014 02:14:41 PM
BONU News: Proxy Statement - Other Information (preliminary) (pre 14c) 08/18/2014 02:36:16 PM
BONU News: Statement of Ownership (sc 13g) 08/07/2014 02:04:27 PM
BONU News: Proxy Statement - Other Information (preliminary) (pre 14c) 07/23/2014 11:56:06 AM
BONU News: Information Statement - All Other (definitive) (def 14c) 07/01/2014 08:24:48 AM
#16544  Sticky Note Regarding the $150M revenue projection.... VortMax 06/12/14 10:29:35 PM
#17606   Who gives a crap,.. Igts all about the thezilla85 09/20/14 11:14:00 PM
#17605   But it's a scam nonetheless. Tens of Black sunshine 09/20/14 12:42:02 PM
#17604   all this hoopla any news with this bag thezilla85 09/20/14 09:58:47 AM
#17603   What revenues Malt? Did I miss something? momoney163 09/19/14 11:47:09 PM
#17602 many farts does it take to get malt66 09/19/14 09:14:33 PM
#17601   David, hey, the screw bag Francis and maybe, malt66 09/19/14 08:59:57 PM
#17600   Fart boy, you miss reality. There is no malt66 09/19/14 08:35:03 PM
#17599   So why you hanging around...fart boy, looking to malt66 09/19/14 08:30:34 PM
#17598   now that's funny! I'm embarrassing myself but yet simon88 09/19/14 07:31:42 PM
#17597   So the bully response as expected and no RamTough2010 09/19/14 05:48:26 PM
#17596   I stand corrected, there is a bigger jackass simon88 09/19/14 01:04:54 PM
#17595   What a joke and fraud PRESIDENT of Revlon ROBINJOY 09/19/14 10:55:59 AM
#17594   Totally agreed Ram! HAE12 09/19/14 08:22:07 AM
#17593   Ok OK , we have many who feel RamTough2010 09/19/14 06:47:11 AM
#17592   I hear he's Lowenthal. momoney163 09/18/14 06:14:30 PM
#17591   hes the same guy along with many other personalities......... ROBINJOY 09/18/14 05:48:53 PM
#17589   RS is of course one option the others ROBINJOY 09/18/14 01:14:55 PM
#17588   The share price may go up big, but lowtotem 09/18/14 11:32:39 AM
#17587   Heard we're going up big this week. momoney163 09/18/14 11:20:26 AM
#17586   Ok...I haven't been looking. Is it to Black sunshine 09/17/14 09:34:23 PM
#17585   They said it is going to happen in momoney163 09/17/14 02:28:56 PM
#17584   Is a RS A Guarantee Here ????????? mwv 09/17/14 11:30:17 AM
#17583   holding strong? you can't be serious.. NO bid simon88 09/15/14 10:14:59 PM
#17582   CDC issues Ebola checklist: 'Now is the time malt66 09/15/14 07:05:30 PM
#17581   Nope...fart boy. Holding strong and well positioned. Quack, quack malt66 09/15/14 06:08:44 PM
#17580   where you hiding Malt? did your pile of simon88 09/15/14 02:39:32 PM
#17579   I'm submitting this to the SEC for investigation . momoney163 09/15/14 11:48:22 AM
#17578   It's the epitome of a scam, what can momoney163 09/15/14 07:49:41 AM
#17577   WE WANT NEWS AND FAST,NO ONE INTERESTED WITH Angel21stCentury 09/14/14 03:46:38 PM
#17576   WHERE IS PURCHASE ORDER TO THIS EMPTY BURNT POTATOE???? Angel21stCentury 09/14/14 03:43:46 PM
#17575   This stock sucks, hasnt had any life in thezilla85 09/14/14 11:06:29 AM
#17574   BONU HAS BEEN RUNNED OVER BY THE BIG Angel21stCentury 09/12/14 05:54:50 PM
#17573   ;-) They all are. momoney163 09/12/14 05:44:04 PM
#17572   ITS A BIG FAT TOXIC BURNT GARBAGE CAN Angel21stCentury 09/12/14 01:48:08 PM
#17571   I can't believe it's not buttter! momoney163 09/12/14 01:15:52 PM
#17570   Don't be silly. They are busy counting all lowtotem 09/12/14 12:04:17 PM
#17569   So...... $BONU couldn't afford to file the report? Penny Profit Prophet 09/11/14 07:54:19 PM
#17568   news---Late filing HAE12 09/11/14 03:57:21 PM
#17567   haha, well crafted Malt. You were able to simon88 09/09/14 03:35:43 PM
#17566   Hey fart, yup I still hold 164 million malt66 09/08/14 06:39:37 PM
#17564   I can't imagine what's going on here. momoney163 09/08/14 01:19:27 PM
#17563   First MNF of the year. Wonder if they momoney163 09/08/14 02:19:09 AM
#17562   For what ? Brentpdc 09/08/14 01:54:45 AM
#17561   Tomorrow is the day!!!! momoney163 09/07/14 08:19:00 PM
#17560   They overpaid courtpuppy 09/07/14 01:55:41 PM
#17559   Someone bought. 1.13 worth. Brentpdc 09/06/14 03:00:16 PM
#17558   They all go through it for cash you'd Brentpdc 09/06/14 02:58:39 PM
#17557   The real problem id Mark Lowenthal he SUCKS ROBINJOY 09/06/14 01:28:57 PM
#17556 Brentpdc 09/06/14 08:38:28 AM
#17555   please provide a link/proof HAE12 09/06/14 07:35:18 AM